ANDA 75593, held by Dr Reddys Labs Ltd. Ciprofloxacin Hydrochloride.
As of Nov 15, 2026, ANDA 75593 (Ciprofloxacin Hydrochloride), held by Dr Reddys Labs Ltd, was first approved by FDA on Jun 9, 2004, with 16 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 9, 2004 | Original application | Approved | None posted |
| Ciprofloxacin HydrochlorideEQ 750MG BASE · tablet;oral | Ciprofloxacin Hydrochloride | Rx |
| Ciprofloxacin HydrochlorideEQ 250MG BASE · tablet;oral | Ciprofloxacin Hydrochloride | Rx |
| Ciprofloxacin HydrochlorideEQ 500MG BASE · tablet;oral | Ciprofloxacin Hydrochloride | Rx |
| Sep 28, 2015 | Supplement 21Labeling · Standard review | Approved | None posted |
| Sep 28, 2015 | Supplement 20Labeling · Standard review | Approved | None posted |
| Mar 27, 2013 | Supplement 19Labeling · Standard review | Approved | None posted |
| Oct 12, 2012 | Supplement 18Labeling | Approved | None posted |
| Feb 27, 2012 | Supplement 16Labeling | Approved | None posted |
| Jan 11, 2012 | Supplement 15Labeling | Approved | None posted |
| Nov 22, 2011 | Supplement 14Labeling | Approved | None posted |
| May 8, 2011 | Supplement 12Labeling | Approved | None posted |
| Apr 30, 2010 | Supplement 10Labeling | Approved | None posted |
| May 20, 2009 | Supplement 9Labeling | Approved | None posted |
| Dec 19, 2008 | Supplement 8Labeling | Approved | None posted |
| May 13, 2008 | Supplement 6Labeling | Approved | None posted |
| Jan 16, 2008 | Supplement 5Labeling | Approved | None posted |
| Oct 5, 2007 | Supplement 4Labeling | Approved | None posted |
| Feb 21, 2007 | Supplement 2Labeling | Approved | None posted |
| Oct 5, 2006 | Supplement 3Labeling | Approved | None posted |
| Jun 9, 2004 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters